Additional Proxy Soliciting Materials (definitive) (defa14a)
April 23 2019 - 4:17PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the Securities
Exchange
Act of 1934 (Amendment No. )
Filed by the Registrant
[X]
|
Filed by a Party other than
the Registrant [ ]
|
|
Check the appropriate
box:
|
|
[ ]
|
|
Preliminary Proxy
Statement
|
[ ]
|
|
Confidential, for Use of the
Commission Only (as permitted by Rule 14a-6(e)(2))
|
[ ]
|
|
Definitive Proxy
Statement
|
[X]
|
|
Definitive Additional
Materials
|
[ ]
|
|
Soliciting Material Pursuant to §240.14a-12
|
|
BioMarin Pharmaceutical Inc.
|
|
|
(Name of Registrant as
Specified In Its Charter)
|
|
|
|
|
|
|
|
|
(Name
of Person(s) Filing Proxy Statement, if other than the
Registrant)
|
|
Payment of Filing Fee (Check
the appropriate box):
|
[X]
|
|
No fee required.
|
[
]
|
|
Fee computed on
table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
|
|
|
|
|
|
|
|
1)
|
|
Title of each class of
securities to which transaction applies:
|
|
|
|
|
|
|
|
2)
|
|
Aggregate number of securities to
which transaction applies:
|
|
|
|
|
|
|
|
3)
|
|
Per unit price or other underlying
value of transaction computed pursuant to Exchange Act Rule 0-11 (set
forth the amount on which the filing fee is calculated and state how it
was determined):
|
|
|
|
|
|
|
|
4)
|
|
Proposed maximum aggregate value of transaction:
|
|
|
|
|
|
|
|
5)
|
|
Total fee paid:
|
|
|
|
|
|
[
]
|
|
Fee paid previously
with preliminary materials.
|
|
|
|
[
]
|
|
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for
which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or
Schedule and the date of its filing.
|
|
|
|
|
|
|
|
1)
|
|
Amount Previously
Paid:
|
|
|
|
|
|
|
|
2)
|
|
Form, Schedule or Registration
Statement No.:
|
|
|
|
|
|
|
|
3)
|
|
Filing Party:
|
|
|
|
|
|
|
|
4)
|
|
Date Filed:
|
|
|
|
|
|
*** Exercise Your
Right
to Vote ***
Important Notice
Regarding the Availability of Proxy Materials for the
Stockholder Meeting to Be Held on June 04, 2019
BIOMARIN PHARMACEUTICAL INC.
BIOMARIN PHARMACEUTICAL INC.
105 DIGITAL DRIVE
NOVATO, CA 94949
ATTN: G. ERIC DAVIS, EVP & GENERAL
COUNSEL
Meeting Information
|
|
Meeting Type:
Annual Meeting
|
|
|
For holders as of:
April 08, 2019
|
|
|
Date:
June 04, 2019
Time:
9:00 AM PDT
|
|
|
Location:
|
BioMarin Pharmaceutical Inc.
|
|
|
|
Morning Glory Conference Room
|
|
|
|
750 Lindaro Street
|
|
|
|
San Rafael, CA 94901
|
|
|
|
For Directions, visit www.biomarin.com - "Contact us"
|
|
You are receiving this communication because you hold shares in the above named company.
This is not a ballot. You cannot use this notice to vote these shares. This communication presents only an overview of the more complete proxy materials that are available to you on the Internet. You may view the
proxy materials online at
www.proxyvote.com
or easily request a paper copy (see reverse side).
We encourage you to access and review all of the important information contained in the proxy materials before voting.
See the reverse side of this notice to obtain proxy
materials and voting instructions.
|
— Before You Vote —
How to Access the Proxy Materials
|
Proxy Materials Available
to VIEW or RECEIVE:
|
|
|
1. Notice & Proxy Statement 2. Form 10-K 3. CEO Stockholder
Letter
|
|
|
How to View Online:
|
|
|
|
|
Have the information that is printed in the box marked by the arrow →
XXXX XXXX XXXX XXXX
(located on the following page) and visit:
www.proxyvote.com.
|
|
|
How to Request and Receive a PAPER or E-MAIL Copy:
|
|
|
If you want to receive a paper or e-mail copy of these documents, you must request one. There is NO charge for requesting a copy. Please
choose one of the following methods to make your request:
|
|
|
|
1)
BY INTERNET
:
|
www.proxyvote.com
|
|
|
|
2)
BY TELEPHONE:
|
1-800-579-1639
|
|
|
|
3)
BY E-MAIL*
:
|
sendmaterial@proxyvote.com
|
|
|
* If requesting materials by e-mail, please send a blank e-mail with the information that is printed in the
box marked by the arrow →
XXXX XXXX XXXX XXXX
(located on the following page) in the subject line.
Requests, instructions and other inquiries sent to this e-mail address will NOT be forwarded to your investment advisor. Please make the request as instructed above on or before
May 21, 2019 to facilitate timely delivery.
|
|
— How To Vote —
Please Choose One of the Following Voting Methods
|
Vote In Person:
Many stockholder meetings have attendance requirements including,
but not limited to, the possession of an attendance ticket issued by the entity holding the meeting. Please check the meeting materials for any special requirements for meeting attendance. At the meeting, you will need to request a ballot to vote these
shares.
|
|
|
Vote By Internet:
To vote now by Internet, go to
www.proxyvote.com.
Have the information that is printed in the box marked by the arrow →
XXXX XXXX XXXX XXXX
available and follow the instructions.
|
|
|
Vote By Mail:
You can vote by mail by requesting a paper copy of the materials, which will include a proxy card.
|
|
|
|
|
Voting items
|
The Board of Directors recommends you vote
FOR the following:
|
1.
|
|
Election of Directors
|
|
|
Nominees
|
01
|
Jean-Jacques Bienaimé
|
|
02
|
Willard Dere
|
|
03
|
Michael Grey
|
|
04
|
Elaine J. Heron
|
|
05
|
Robert J. Hombach
|
06
|
V. Bryan Lawlis
|
|
07
|
Alan J. Lewis
|
|
08
|
Richard A. Meier
|
|
09
|
David E.I. Pyott
|
|
10
|
Dennis J. Slamon
|
The Board of Directors recommends you vote FOR proposals 2, 3, 4 and
5.
2
|
To ratify the selection of KPMG LLP as the independent registered public accounting firm for BioMarin for the fiscal year ending December 31, 2019.
|
|
|
3
|
To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as disclosed in the Proxy Statement.
|
|
|
4
|
To approve an amendment to the 2017 Equity Incentive Plan.
|
|
|
5
|
To approve amendments to the Amended and Restated 2006 Employee Stock Purchase Plan.
|
NOTE:
Your proxy holder will also vote on any other business properly brought before the Annual Meeting.
|
|
|
|
|
|
BioMarin Pharmaceutical (NASDAQ:BMRN)
Historical Stock Chart
From Aug 2024 to Sep 2024
BioMarin Pharmaceutical (NASDAQ:BMRN)
Historical Stock Chart
From Sep 2023 to Sep 2024